Consumer healthcare company, GlaxoSmithKline (GSK) Nigeria Plc’s 2019 full-year revenue increased 12.8percent to N20.78bn from N18.41bn. The company’s cost of sales surged 20.5percent to N15.05bn from N12.48bn leaving gross profit at N5.73bn from N5.92bn. Selling and distribution expenses jum
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp